Giant warts in a kidney transplant patient: Regression with sirolimus

British Journal of Dermatology

Volumn 162, Issue 5, 2010, Pages 1148-1150

  Kostaki, M ^a   Venetz, J P ^b   Nseir, G ^b   Meylan, P ^b   Sahli, R ^b   Pascual, M ^b   Laffitte, E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Kidney transplantation; Sirolimus; Warts

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VIRUS DNA;

ADULT; CASE REPORT; CORTICOSTEROID INDUCED OSTEOPOROSIS; CREATININE BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL DISEASE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 57; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; MICROCYTIC ANEMIA; MOUTH ULCER; PALMOPLANTAR KERATODERMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME; VERRUCA PLANTARIS; VIRUS IDENTIFICATION; WART VIRUS;

HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SIROLIMUS; WARTS;

EID: 77951214226     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09687.x     Document Type: Letter

References (10)

1. Monoley FJ, Keane S, O'Kelly P et al. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol 2005 153 : 574 578.
2. Purdie KJ, Surentheran T, Sterling JC et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 2005 125 : 98 107.
3. Pruvost C, Penso-Assathiany D, Bachot N et al. Risk factors for cutaneous wart onset in transplant recipients. Ann Dermatol Venereol 2002 129 : 291 293.
4. Campistol JM, Eris J, Oberbauer R et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk of cancer in adult renal transplantation. J Am Soc Nephrol 2006 17 : 581 589.
5. Stallone G, Schena A, Infante B et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005 352 : 1317 1323.
6. Roy J, Paquette JS, Fortin JF, Tremblay MJ. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother 2002 46 : 3447 3455.
7. D'Ambrogio A, Yerly S, Sahli R et al. Human papilloma virus type and recurrence rate after surgical clearance of anal condylomata acuminata. Sex Transm Dis 2009 36 : 536 540.
8. Oh KJ, Kalinina A, Park NH, Baqchi S. Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein. J Virol 2006 80 : 7079 7088.
9. Bonatti H, Aigner F, De Clercq E et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Tranpl Int 2007 20 : 238 246.
10. Dharancy S, Catteau B, Mortier L et al. Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient. Liver Transpl 2006 12 : 1883 1887.